“Efficacy of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis With Severe Itch at Baseline and in Subgroups by Baseline Thresholds of Severe Itch: A Post Hoc Analysis of the JADE COMPARE and JADE DARE Clinical Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s380. Accessed May 19, 2025. https://skin.dermsquared.com/skin/article/view/2691.